#
Orakl Oncology
Exclusive: Orakl Oncology raises $34m to test cancer drugs on ‘virtual patients’
Pro
Exclusive
November 12, 2026
Exclusive: Orakl Oncology raises $34m to test cancer drugs on ‘virtual patients’
Swedish investor Norrsken and Paris-based VC Singular co-led the round
Daphné Leprince-Ringuet